REIC/Dkk-3 is involved in the early development of squamous cell carcinoma.
REIC/Dkk-3 inhibited the formation of cutaneous squamous cell carcinoma in vivo test.
The anti-cancer effect of REIC/Dkk-3 may arise from suppression of tumorigenic cancer cells and the regulation of cell cycle.